Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAIM ImmunoTech Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
AIM ImmunoTech Inc. Earnings Date And Information
AIM ImmunoTech Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.1 by $0.04. The company had revenue of 35,000 for the quarter and had revenue of 202,000 for the year. AIM ImmunoTech Inc. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -0.3. AIM ImmunoTech Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based on prior year's report dates.
AIM ImmunoTech Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.10 | -$0.06 | 0.04 | $17,500 | $35,000 |
| 08/14/2024 | Q2 2024 | -$0.12 | -$0.03 | 0.09 | $17,500 | $50,000 |
| 05/15/2024 | Q1 2024 | N/A | -$0.12 | N/A | N/A | $40,000 |
| 03/29/2024 | Q4 2023 | N/A | -$0.26 | N/A | N/A | $65,000 |
| 11/14/2023 | Q3 2023 | -$0.11 | -$0.16 | -0.05 | $24,000 | $46,000 |
| 08/14/2023 | Q2 2023 | N/A | -$0.10 | N/A | $23,000 | $42,000 |
| 05/12/2023 | Q1 2023 | N/A | -$0.06 | N/A | N/A | $49,000 |
| 03/31/2023 | Q4 2022 | N/A | $0.00 | N/A | N/A | $56,000 |
| 11/14/2022 | Q3 2022 | N/A | -$0.13 | N/A | $210,000 | $21,000 |
| 08/15/2022 | Q2 2022 | -$0.07 | -$0.10 | -0.03 | $137,667 | $30,000 |
| 05/13/2022 | Q1 2022 | N/A | -$0.09 | N/A | N/A | $33,000 |
| 03/31/2022 | Q4 2021 | -$0.08 | -$0.12 | -0.04 | N/A | $50,000 |
| 11/15/2021 | Q3 2021 | N/A | -$0.08 | N/A | $38,333 | $33,000 |
| 08/16/2021 | Q2 2021 | N/A | -$0.12 | N/A | $349,333 | $23,000 |
| 05/17/2021 | Q1 2021 | N/A | -$0.08 | N/A | N/A | $28,000 |
| 03/30/2021 | Q4 2020 | -$0.07 | -$0.09 | -0.02 | N/A | $42,000 |
| 11/12/2020 | Q3 2020 | N/A | -$0.09 | N/A | $360,000 | $36,000 |
| 08/14/2020 | Q2 2020 | -$0.10 | -$0.11 | -0.01 | $51,000 | $40,000 |
| 05/13/2020 | Q1 2020 | N/A | -$0.22 | N/A | N/A | $45,000 |
| 03/30/2020 | Q4 2019 | -$0.37 | -$0.07 | 0.3 | N/A | $50,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AIM ImmunoTech Inc. Earnings: FAQ's
AIM ImmunoTech Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based offlast year's report dates.
In the previous quarter, AIM ImmunoTech Inc. (:AIM) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.1 by $0.04.
The conference call for AIM ImmunoTech Inc.'s latest earnings report can be listened to online.
The conference call transcript for AIM ImmunoTech Inc.'s latest earnings report can be read online.
AIM ImmunoTech Inc. (:AIM) has a recorded annual revenue of $202,000.
AIM ImmunoTech Inc. (:AIM) has a recorded net income of $-28,962,000.AIM ImmunoTech Inc. has generated $-0.6 earnings per share over the last four quarters.
AIM ImmunoTech Inc. (:AIM) has a price-to-earnings ratio of -0.3 and price/earnings-to-growth ratio is -0.02.